ATE496031T1 - Für die behandlung von auf die modulierung des dopamin-d3-rezeptors ansprechende erkrankungen geeignete aryloxyethylaminverbindungen - Google Patents

Für die behandlung von auf die modulierung des dopamin-d3-rezeptors ansprechende erkrankungen geeignete aryloxyethylaminverbindungen

Info

Publication number
ATE496031T1
ATE496031T1 AT07728098T AT07728098T ATE496031T1 AT E496031 T1 ATE496031 T1 AT E496031T1 AT 07728098 T AT07728098 T AT 07728098T AT 07728098 T AT07728098 T AT 07728098T AT E496031 T1 ATE496031 T1 AT E496031T1
Authority
AT
Austria
Prior art keywords
treatment
dopamine
receptor
modulation
compounds suitable
Prior art date
Application number
AT07728098T
Other languages
English (en)
Inventor
Roland Grandel
Wilfried Martin Braje
Andreas Haupt
Sean Colm Turner
Udo Lange
Karla Drescher
Liliane Unger
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Priority claimed from PCT/EP2007/053633 external-priority patent/WO2007118859A1/en
Application granted granted Critical
Publication of ATE496031T1 publication Critical patent/ATE496031T1/de

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT07728098T 2006-04-14 2007-04-13 Für die behandlung von auf die modulierung des dopamin-d3-rezeptors ansprechende erkrankungen geeignete aryloxyethylaminverbindungen ATE496031T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06007923 2006-04-14
US79367106P 2006-04-20 2006-04-20
PCT/EP2007/053633 WO2007118859A1 (en) 2006-04-14 2007-04-13 Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor

Publications (1)

Publication Number Publication Date
ATE496031T1 true ATE496031T1 (de) 2011-02-15

Family

ID=40631425

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07728098T ATE496031T1 (de) 2006-04-14 2007-04-13 Für die behandlung von auf die modulierung des dopamin-d3-rezeptors ansprechende erkrankungen geeignete aryloxyethylaminverbindungen

Country Status (6)

Country Link
CN (1) CN101421243B (de)
AT (1) ATE496031T1 (de)
DE (1) DE602007012071D1 (de)
ES (1) ES2360254T3 (de)
PE (1) PE20080057A1 (de)
TW (1) TWI400233B (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW450954B (en) * 1998-05-14 2001-08-21 Pharmacia & Amp Upjohn Company Phenylsulfonamide-phenylethylamines useful as dopamine receptors
US20050085461A1 (en) * 2002-02-13 2005-04-21 Cooper David G. Benzenesulfonamide derivatives
GB0411421D0 (en) * 2004-05-21 2004-06-23 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
TW200808727A (en) 2008-02-16
DE602007012071D1 (de) 2011-03-03
PE20080057A1 (es) 2008-03-10
CN101421243B (zh) 2012-05-30
ES2360254T3 (es) 2011-06-02
TWI400233B (zh) 2013-07-01
CN101421243A (zh) 2009-04-29

Similar Documents

Publication Publication Date Title
EA201200318A1 (ru) Гетероциклические оксимы
EA201290078A1 (ru) Гетероциклические соединения для ингибирования pask
PL2150530T3 (pl) Podstawione pochodne sulfonamidu
GB0722077D0 (en) Compounds
NZ600210A (en) Substituted 4-aminocyclohexane derivatives
UA107112C2 (uk) Активатори розчинної гуанілатциклази
EA201200260A1 (ru) Гетероциклические гидразоны и их применение для лечения рака и воспаления
EA201101671A1 (ru) Замещенные производные аминопропионовой кислоты в качестве ингибиторов неприлизина
MX2008013212A (es) 4-anilinquinolina-3-carboxamidas como inhibidores de la cinsa csf-1r.
PH12012500622A1 (en) Compounds for the treatment of dyslipidemia and related diseases
EA201792071A3 (ru) Производные глутаримидов, их применение, фармацевтическая композиция на их основе, способы их получения
TN2009000275A1 (en) Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
IN2012DN00953A (de)
BR112012020060B8 (pt) uso de n-((1-((4-hidroxitetrahidro-2h-piran-4-il)metil)piperidin-4-il)metil)-3-isopropil-2-oxo-2,3-dihidro-1h-benzo[d]imidazol-1-carboxamida para tratar doença de alzheimer e demência
MX2009013482A (es) Derivados de [1,10]-fenantrolina para el tratamiento de enfermedades neurodegenerativas o hematologicas.
MX2016004847A (es) Derivados de piperazina y su uso como medicamento.
GEP20125526B (en) Drug active in neuropathic pain
SG10201809506TA (en) Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
MY160005A (en) 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt
ATE502008T1 (de) Zur behandlung von auf die modulation des dopamin-d3-rezeptors ansprechenden erkrankungen geeignete aminomethylsubstituierte bicyclische aromatische verbindungen
EA201070478A1 (ru) Дифенилкарбоновые кислоты и их производные
ATE540922T1 (de) Zur behandlung von erkrankungen, die auf eine modulation des dopamin-d3-rezeptors ansprechen, geeignete aminoethylaromatische verbindungen
DE602005001918D1 (de) S-tenatoprazolnatrium-monohydrat-salz und dessen verwendung in form eines protonenpumpenhemmers
DOP2012000061A (es) Utilizacion de derivados del indol como activadores de nurr-1, para la aplicacion en tratamientos de enfermedades como el parkinson
DOP2007000074A (es) Compuestos de ariloxietilamina apropiados para tratar trastornos que responden a la modulación del receptor de dopamina d3

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties